Stem cell therapy trials for arthritis are advancing research into regenerative treatments aimed at repairing joint damage and reducing inflammation. These clinical trials are critical for evaluating safety and effectiveness.
Arthritis, affecting millions worldwide, often leads to pain and reduced mobility. Stem cells could offer an alternative to traditional medications by promoting tissue regeneration and modulating immune responses.
Current trials focus on mesenchymal stem cells sourced from bone marrow or fat tissue, injected directly into affected joints. Early results show potential improvements in pain relief and cartilage repair.
Researchers are also investigating optimal dosing, delivery methods, and patient selection to maximize benefits and minimize risks. Regulatory approvals will depend on the outcomes of these rigorous studies.
